openPR Logo
Press release

Growing Cancer Prevalence Is Anticipated To Fuel The Flow Cytometry In The Oncology And Immunology Market Growth: Strengthening the Growth Trajectory of the Flow Cytometry In Oncology And Immunology Market

07-16-2025 07:50 AM CET | Health & Medicine

Press release from: The Business Research Company

Flow Cytometry In Oncology And Immunology

Flow Cytometry In Oncology And Immunology

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Flow Cytometry In Oncology And Immunology Market Through 2025?
The oncology and immunology market for flow cytometry has seen quick expansion in the past few years. It is projected to escalate from a value of $2.11 billion in 2024 to reach $2.33 billion by 2025, maintaining a compound annual growth rate (CAGR) of 10.4%. Factors contributing to the growth during the historical timeframe include progress in cancer and immunology studies, an increase in diagnostic applications, a growing number of autoimmune diseases, drug development, and ongoing clinical trials.

What's the Projected Size of the Global Flow Cytometry In Oncology And Immunology Market by 2029?
An explosive increment is anticipated in the market size of flow cytometry in oncology and immunology in the impending years. A growth of up to $3.46 billion is projected by 2029 with a compound annual growth rate (CAGR) of 10.4%. The upcoming period's expansion can be correlated with integrations into genomics and proteomics, the uptake of single-cell analysis, ballooning applications in the field of infectious diseases, an escalating count of cancer cases, and point-of-care flow cytometry. The key trends identified for the forecast duration encompass immunophenotyping in the realm of immunotherapy, downscaling of flow cytometry systems, multiparametric analysis, a pivot towards spectral flow cytometry along with cooperative research schemes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Top Growth Drivers in the Flow Cytometry In Oncology And Immunology Industry: What's Accelerating the Market?
The escalating incidences of cancer are anticipated to fuel the expansion of flow cytometry in the field of oncology and immunology. Cancer is an umbrella term for a collection of illnesses marked by the unregulated multiplication and dissemination of abnormal cells within the body. Flow cytometry is a prevalent methodology employed in oncology and immunology for the examination of cancer and immune cells. For instance, information from the Macmillan Cancer Support, a healthcare charity based in the UK, revealed that 3 million individuals were diagnosed with cancer in 2020. The forecast highlights an estimated growth that could affect 3.5 million people by 2025, 4 million by 2030, and 5.3 million by 2040. Consequently, the rising frequency of cancer is bolstering the expansion of flow cytometry in the oncology and immunology market sectors.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp

What Trends Will Shape the Flow Cytometry In Oncology And Immunology Market Through 2029 and Beyond?
In the oncology and immunology markets, a prominent trend is the adoption of technological innovations in the field of flow cytometry. To maintain a competitive edge, major firms in this sector are embracing new technologies. For instance, in September 2022, Becton Dickinson, a US-based provider of medical technology, introduced the BD Research Cloud for flow cytometry in the areas of oncology and immunology. This cloud-based software system simplifies the flow cytometry process for researchers working in diverse areas, such as immunology, virology, infectious disease, and cancer monitoring, thus expediting higher-quality studies with faster insights. Innovative technologies like BD Horizon RealYellow and RealBlue Reagents, as well as the newly launched BD FACSDiscover S8 Cell Sorter equipped with BD CellView Image Technology, are being harnessed by BD. These advancements enhance flow cytometry capabilities, empowering researchers to facilitate and push the boundaries of their pioneering studies. Tailored specifically for BD equipment and reagents, the BD Research Cloud operates on an industry-standard cloud infrastructure.

What Are the Main Segments in the Flow Cytometry In Oncology And Immunology Market?
The flow cytometry in oncology and immunology market covered in this report is segmented -

1) By Type: Immunology, Oncology
2) By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
3) By Application: Translational Research, Clinical Research
4) By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users

Subsegments:
1) By Immunology: Immune Cell Profiling, Cytokine Detection, T-Cell And B-Cell Analysis, Autoimmune Disease Testing
2) By Oncology: Cancer Cell Analysis, Tumor Microenvironment Studies, Minimal Residual Disease Detection, Biomarker Discovery And Validation

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12469&type=smp

Which Top Companies are Driving Growth in the Flow Cytometry In Oncology And Immunology Market?
Major companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason

Which Regions Will Dominate the Flow Cytometry In Oncology And Immunology Market Through 2029?
North America was the largest region in the flow cytometry in oncology and immunology market in 2024. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growing Cancer Prevalence Is Anticipated To Fuel The Flow Cytometry In The Oncology And Immunology Market Growth: Strengthening the Growth Trajectory of the Flow Cytometry In Oncology And Immunology Market here

News-ID: 4105616 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Flow

Flow (FLOW) Price Prediction: Pepenode (PEPENODE) Gains Rapid Market Recognition
Market moves since early October have reshaped speculative flows. Bitcoin slid from roughly $126,080 to about $87,423, wiping nearly $1 trillion from total market value and pressuring Ethereum. That unwind pushed ETH down about 28% over 30 days and coincided with a $415M net outflow from spot funds in a single day. Rising U.S. Treasury yields and shifting Federal Reserve expectations have nudged capital toward perceived safety and yield-bearing strategies. Institutional
Flow Rate Liquid Flow Meters Market Size, Share and Growth Report, 2034
"The global liquid flow meter market was valued at approximately USD 4 billion in 2024 and is projected to reach around USD 6.5 billion by 2034, indicating a Compound Annual Growth Rate (CAGR) of about 5.2% over the forecast period from 2025 to 2034. " Exactitude Consultancy., Ltd. released a research report titled "Flow Rate Liquid Flow Meters Market". This report covers the global Flow Rate Liquid Flow Meters market sales,
Hybrid Flow Battery Market, By Type (Zinc Bromine Flow Batteries, Other Hybrid F …
Data Bridge Market Research analyses the hybrid flow battery market will exhibit a CAGR of 32.14% for the forecast period of 2022-2029 and is likely to reach USD 710.18 million by 2029. View Detailed Analysis Report: https://www.databridgemarketresearch.com/reports/global-hybrid-flow-battery-market The zinc-bromine flow battery (ZBFB) is the most well-known form of hybrid flow battery. Typically, a hybrid flow battery consists of a cell with 2 compartments separated by a microporous membrane. The battery has a
Hybrid Flow Battery Market, By Type (Zinc Bromine Flow Batteries, Other Hybrid F …
Data Bridge Market Research analyses the hybrid flow battery market will exhibit a CAGR of 32.14% for the forecast period of 2022-2029 and is likely to reach USD 710.18 million by 2029. View Detailed Report: https://www.databridgemarketresearch.com/reports/global-hybrid-flow-battery-market The zinc-bromine flow battery (ZBFB) is the most well-known form of hybrid flow battery. Typically, a hybrid flow battery consists of a cell with 2 compartments separated by a microporous membrane. The battery has a conductor
Hybrid Flow Battery Market, By Type (Zinc Bromine Flow Batteries, Other Hybrid F …
Data Bridge Market Research analyses the hybrid flow battery market will exhibit a CAGR of 32.14% for the forecast period of 2022-2029 and is likely to reach USD 710.18 million by 2029. View Detailed Report: https://www.databridgemarketresearch.com/reports/global-hybrid-flow-battery-market The zinc-bromine flow battery (ZBFB) is the most well-known form of hybrid flow battery. Typically, a hybrid flow battery consists of a cell with 2 compartments separated by a microporous membrane. The battery has a conductor
Flow Cytometry Market Size 2020-26, Agilent Technologies, Apogee Flow Systems
The latest study on the Global Flow Cytometry market report represents a deep appraisal of the international industry. The research report on the worldwide Flow Cytometry market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Flow Cytometry industry status and authorized projection related to the Flow Cytometry market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also